Featured Research

from universities, journals, and other organizations

HRGP (histadine-rich glycoprotein) modulates angiogenesis

Date:
March 25, 2010
Source:
American Journal of Pathology
Summary:
Scientists have identified HRGP as a new therapeutic target for anti-angiogenic cancer therapies.

Dr. Roy L Silverstein and colleagues of the Cleveland Clinic, Cleveland, OH have identified HRGP as a new therapeutic target for anti-angiogenic cancer therapies.

Related Articles


These results are presented in the April 2010 issue of the American Journal of Pathology.

Glioblastoma, which is the most common and aggressive form of brain tumor in humans, occurs in 2-3 per 100,000 people in the Europe and North America. Inhibiting angiogenesis, or new blood vessel growth, is a major therapeutic strategy for glioblastoma.

Interaction of CD36, a cell surface receptor expressed on the cells that line small blood vessels, with a secreted portion of brain angiogenesis inhibitor 1 (Vstat120) elicits an anti-angiogenic response. Klenotic et al discovered that Vstat120 binding to CD36 activated a pro-apoptotic (cell death-inducing) pathway, which could be blocked by HRGP through HRGP-Vstat120 binding. The HRGP-Vstat120 interaction restored endothelial cell migration and tube formation and increased brain tumor growth with corresponding increases in tumor blood vessel development. Indeed, HRGP expression levels were increased in human brain cancers, indicating that this angiogenic axis could provide a therapeutic target for anti-angiogenic cancer therapies.

The study by Klenotic et al suggests that "in conditions where neo-vasculature is poorly organized and "leaky," such as in tumor beds, or where platelet activation occurs, such as in a wound or inflammatory site, HRGP can accumulate in the extracellular matrix and abrogate the potent anti-angiogenic activity of a broad class of angiogenesis inhibitors."


Story Source:

The above story is based on materials provided by American Journal of Pathology. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. A. Klenotic, P. Huang, J. Palomo, B. Kaur, E. G. Van Meir, M. A. Vogelbaum, M. Febbraio, C. L. Gladson, R. L. Silverstein. Histidine-Rich Glycoprotein Modulates the Anti-Angiogenic Effects of Vasculostatin. American Journal Of Pathology, 2010; DOI: 10.2353/ajpath.2010.090782

Cite This Page:

American Journal of Pathology. "HRGP (histadine-rich glycoprotein) modulates angiogenesis." ScienceDaily. ScienceDaily, 25 March 2010. <www.sciencedaily.com/releases/2010/03/100325225615.htm>.
American Journal of Pathology. (2010, March 25). HRGP (histadine-rich glycoprotein) modulates angiogenesis. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2010/03/100325225615.htm
American Journal of Pathology. "HRGP (histadine-rich glycoprotein) modulates angiogenesis." ScienceDaily. www.sciencedaily.com/releases/2010/03/100325225615.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins